This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Aniridia Type 1
Information about Aniridia Type 1: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Aniridia Type 1
Most recent studies have shown that Aniridia Type 1 shares some biological mechanisms with aniridia, aniridia-type-2, coronary-heart-disease, dehydration, edema, infectious-mononucleosis, malignant-neoplasms, malnutrition, neoplasms, pediatric-neoplasm, peripheral-nerve-injuries, physiological-stress, reperfusion-injury, somatotropin-deficiency, substance-related-disorders, tissue-adhesions, urination-disorders.
Among the many pathways, these few ones have gauged particular interests from scientists studying Aniridia Type 1, and have been seen in publications frequently: Biofilm Formation, Cell Activation, Cell Adhesion, Cell Differentiation, Cell Proliferation, Epidermal Cell Differentiation, Flower Development, Germination, Habituation, Localization, Mating, Nitrogen Fixation, Pigment Accumulation, Pigmentation, Seed Coat Development, Seed Maturation, Translation, Transpiration, Transposition, Vacuolar Acidification
Quite a number of genes have been found to play important roles in Aniridia Type 1, such as AGA, APCS, CACFD1, CYP27A1, GLS2, HNRNPC, INS, MYB, NOD2, PAX6, POMC, RPL10, SGCA, SH2D1A, TNF, TNFAIP3, TNFSF14, XIAP, ZFAND6. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.